Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

{[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

Quality Control of N-EtOC-Phe-OH Purity: 98% SDS Specification

COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

1-2 Day Shipping
High Quality
Technical Support

Product Details of N-EtOC-Phe-OH

CAS No. :	19887-32-2
Formula :	C₁₂H₁₅NO₄
M.W :	237.25
SMILES Code :	O=C(O)[C@@H](NC(OCC)=O)CC1=CC=CC=C1
MDL No. :	MFCD00830554
InChI Key :	YUBBGLSAFZJOMD-JTQLQIEISA-N
Pubchem ID :	2817957

Safety of N-EtOC-Phe-OH

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P280-P301+P312-P302+P352-P305+P351+P338

Application In Synthesis of N-EtOC-Phe-OH

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Downstream synthetic route of [ 19887-32-2 ]

[ 19887-32-2 ] Synthesis Path-Downstream 1~35

1
[ 50-00-0 ]
[ 19887-32-2 ]
[ 55740-08-4 ]

References: [1]Bulletin de la Societe Chimique de France,1974,p. 2857 - 2860.

2
[ 100-02-7 ]
[ 19887-32-2 ]
[ 70930-37-9 ]

References: [1]Chemistry Letters,1979,p. 491 - 494.

3
[ 2666-93-5 ]
[ 19887-32-2 ]
[ 117161-18-9 ]

References: [1]Journal of Medicinal Chemistry,1988,vol. 31,p. 2264 - 2276.

4
[ 63-91-2 ]
[ 74877-64-8 ]
[ 19887-32-2 ]

References: [1]Journal of Organic Chemistry,1980,vol. 45,p. 4519 - 4522.

5
[ 2577-90-4 ]
[ 19887-32-2 ]
[ 117161-19-0 ]

References: [1]Journal of Medicinal Chemistry,1988,vol. 31,p. 2264 - 2276.

6
[ 19887-32-2 ]
{(2R,3S)-3-[(S)-2-Amino-3-(1H-imidazol-4-yl)-propionylamino]-4-cyclohexyl-2-hydroxy-butyl}-phosphonic acid dimethyl ester; hydrochloride [ No CAS ]
[ 123381-44-2 ]

References: [1]Journal of Medicinal Chemistry,1990,vol. 33,p. 534 - 542.

7
[ 19887-32-2 ]
(4S,5S)-5-[(S)-2-Amino-3-(1H-imidazol-4-yl)-propionylamino]-6-cyclohexyl-4-hydroxy-2-methylene-hexanoic acid (3-methyl-butyl)-amide; hydrochloride [ No CAS ]
[ 110613-44-0 ]

References: [1]Journal of Medicinal Chemistry,1987,vol. 30,p. 1978 - 1983.

8
[ 19887-32-2 ]
(S)-2-Amino-N-[(1S,2S)-1-cyclohexylmethyl-2-hydroxy-4-(propane-2-sulfonyl)-butyl]-3-(1H-imidazol-4-yl)-propionamide; hydrochloride [ No CAS ]
{(S)-1-[(S)-1-[(1S,2S)-1-Cyclohexylmethyl-2-hydroxy-4-(propane-2-sulfonyl)-butylcarbamoyl]-2-(1H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-carbamic acid ethyl ester [ No CAS ]

References: [1]Journal of Medicinal Chemistry,1987,vol. 30,p. 1729 - 1737.

9
[ 63-91-2 ]
[ 541-41-3 ]
[ 19887-32-2 ]

Yield	Reaction Conditions	Operation in experiment
		General procedure: The L-amino acid (10.0 g) wasdissolved in H2O (300 mL), and Na2CO3 (2.0 equiv) andNaHCO3 (1.0 equiv) were added at room temperature, withstirring, to give a clear solution. Acetone (4.0 vol.) wasadded, and the slightly turbid solution was cooled in an icewater bath to 15-20C. THen, ethyl chloroformate (1.5 equiv)was added slowly, with stirring, and the reaction mixtureallowed to warm, to r.t. After stirring for an additional 3 h,the organic layer was concentrated under vacuum. To theaqueous phase was slowly added aqueous HCl, to give a pHof 2. The resulting mixture was extracted into EtOAc(150 mL), and this was washed with H2O (100 mL) and thenconcentrated in vacuum to give the N-protected amino acid,an oil.

References: [1]Tetrahedron Asymmetry,2002,vol. 13,p. 945 - 951.
[2]Journal of Organic Chemistry,1995,vol. 60,p. 7256 - 7266.
[3]Journal of Organic Chemistry,1985,vol. 50,p. 3972 - 3979.
[4]Journal of Organic Chemistry,2005,vol. 70,p. 9940 - 9946.
[5]Canadian Journal of Chemistry,1987,vol. 65,p. 1224 - 1227.
[6]Journal of Medicinal Chemistry,1988,vol. 31,p. 2264 - 2276.
[7]Synthesis,2004,p. 1589 - 1594.
[8]Organic Letters,2005,vol. 7,p. 2755 - 2758.
[9]Journal of Chemistry,2019,vol. 2019.

10
[ 70930-37-9 ]
[ 100-02-7 ]
[ 19887-32-2 ]

References: [1]Recueil des Travaux Chimiques des Pays-Bas,1993,vol. 112,p. 1 - 6.

11
[ 70930-37-9 ]
[ 19887-32-2 ]

References: [1]Recueil des Travaux Chimiques des Pays-Bas,1992,vol. 111,p. 459 - 468.

12
[ 19887-32-2 ]
[ 108-12-3 ]
C₁₇H₂₃NO₅ [ No CAS ]

References: [1]Journal of Organic Chemistry,1985,vol. 50,p. 3972 - 3979.

13
[ 19887-32-2 ]
[ 104882-10-2 ]
[ 17791-52-5 ]
{(S)-1-[(S)-1-((1S,2R,3S)-1-Cyclohexylmethyl-2,3-dihydroxy-5-methyl-hexylcarbamoyl)-2-(1H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-carbamic acid ethyl ester [ No CAS ]

References: [1]Journal of Medicinal Chemistry,1988,vol. 31,p. 2264 - 2276.

14
[ 19887-32-2 ]
[ 117248-32-5 ]
[ 17791-52-5 ]
{(S)-1-[(S)-1-((1S,2R,3S)-1-Cyclohexylmethyl-2,3-dihydroxy-pentylcarbamoyl)-2-(1H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-carbamic acid ethyl ester [ No CAS ]

References: [1]Journal of Medicinal Chemistry,1988,vol. 31,p. 2264 - 2276.

15
[ 19887-32-2 ]
[ 79972-54-6 ]
(1'S,2S)-2-<(Ethoxycarbonyl)amino>-3-phenylpropionic acid 1-vinylpent-4-enyl ester [ No CAS ]
(1'R,2S)-2-<(Ethoxycarbonyl)amino>-3-phenylpropionic acid 1-vinylpent-4-enyl ester [ No CAS ]

References: [1]Journal of Organic Chemistry,1995,vol. 60,p. 7256 - 7266.

16
[ 2033-24-1 ]
[ 19887-32-2 ]
[(S)-1-Benzyl-2-(2,2-dimethyl-4,6-dioxo-[1,3]dioxan-5-ylidene)-ethyl]-carbamic acid ethyl ester [ No CAS ]

References: [1]Tetrahedron Asymmetry,1996,vol. 7,p. 2365 - 2370.

18
[ 19887-32-2 ]
[ 117155-95-0 ]

References: [1]Tetrahedron Asymmetry,2002,vol. 13,p. 945 - 951.
[2]Angewandte Chemie - International Edition,2013,vol. 52,p. 13365 - 13368.
Angew. Chem.,2013,vol. 125,p. 13607 - 13610.

19
[ 19227-13-5 ]
[ 19887-32-2 ]
ethyl [(S)-1-(3-p-tolyl-1,2,4-oxadiazol-5-yl)-2-phenylethyl]carbamate [ No CAS ]